Gland Pharma Limited

NSEI:GLAND Voorraadrapport

Marktkapitalisatie: ₹288.2b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Gland Pharma Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Srinivas Sadu

Algemeen directeur

₹70.2m

Totale compensatie

Percentage CEO-salaris95.3%
Dienstverband CEO5.5yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijnless than a year
Gemiddelde ambtstermijn bestuur4.1yrs

Recente managementupdates

Recent updates

Gland Pharma (NSE:GLAND) Has A Pretty Healthy Balance Sheet

Oct 01
Gland Pharma (NSE:GLAND) Has A Pretty Healthy Balance Sheet

Investors Still Waiting For A Pull Back In Gland Pharma Limited (NSE:GLAND)

Sep 05
Investors Still Waiting For A Pull Back In Gland Pharma Limited (NSE:GLAND)

Gland Pharma Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 09
Gland Pharma Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Jun 22
Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

May 25
Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

Is Gland Pharma (NSE:GLAND) A Risky Investment?

Mar 19
Is Gland Pharma (NSE:GLAND) A Risky Investment?

Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Feb 16
Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

May 20
Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 07
Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Jul 22
Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Jul 14
Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Feb 08
Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Analyse CEO-vergoeding

Hoe is Srinivas Sadu's beloning veranderd ten opzichte van Gland Pharma's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

₹7b

Mar 31 2024₹70m₹67m

₹8b

Dec 31 2023n/an/a

₹7b

Sep 30 2023n/an/a

₹7b

Jun 30 2023n/an/a

₹7b

Mar 31 2023₹124m₹61m

₹8b

Dec 31 2022n/an/a

₹10b

Sep 30 2022n/an/a

₹10b

Jun 30 2022n/an/a

₹11b

Mar 31 2022₹124m₹61m

₹12b

Dec 31 2021n/an/a

₹12b

Sep 30 2021n/an/a

₹11b

Jun 30 2021n/an/a

₹10b

Mar 31 2021₹89m₹31m

₹10b

Dec 31 2020n/an/a

₹9b

Jun 30 2020n/an/a

₹9b

Mar 31 2020₹59m₹32m

₹8b

Mar 31 2019₹23mn/a

₹5b

Mar 31 2018₹11m₹5m

₹3b

Compensatie versus markt: De totale vergoeding ($USD 836.89K ) Srinivas } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 581.76K ).

Compensatie versus inkomsten: De vergoeding van Srinivas is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Srinivas Sadu (55 yo)

5.5yrs

Tenure

₹70,150,000

Compensatie

Mr. Srinivas Sadu, B. Pharm, M. S., MBA has been Executive Director and Chief Executive Officer at Gland Pharma Ltd. since April 25, 2019 and serves as its Executive Chairman from June 10, 2024. He had bee...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Srinivas Sadu
CEO & Executive Chairman5.5yrs₹70.15mgeen gegevens
Ravi Mitra
Chief Financial Officer5.1yrs₹20.45mgeen gegevens
Sampath Pallerlamudi
Company Secretary & Vice-President of Compliance & CSRno data₹6.05mgeen gegevens
Satnam Loomba
Chief Operating Officerless than a yeargeen gegevensgeen gegevens
Ankit Gupta
Head of Investments1.1yrsgeen gegevensgeen gegevens
Surinder Koul
Head of Domestic Marketingless than a yeargeen gegevensgeen gegevens
Surapanini Sridevi
Senior Vice President of R&Dno datageen gegevensgeen gegevens
K Rao
Head of Qualityless than a yeargeen gegevens0.0012%
₹ 3.6m
Rong Wu
Chief Financial Controllerno datageen gegevens0.000020%
₹ 57.6k

0.8yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van GLAND wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Srinivas Sadu
CEO & Executive Chairman5.5yrs₹70.15mgeen gegevens
Naina Lal Kidwai
Independent Director3.4yrs₹10.50mgeen gegevens
Udo Vetter
Independent Director6.7yrs₹3.00mgeen gegevens
Essaji Vahanvati
Independent Director4.1yrs₹3.00mgeen gegevens
Wenjie Zhang
Non-Executive and Non-Independent Directorless than a yeargeen gegevensgeen gegevens
Jia Ai Zhang
Non-Independent Non Executive Director3.4yrsgeen gegevensgeen gegevens
Satyanarayana Chavali
Independent Director5.9yrs₹3.00mgeen gegevens

4.1yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van GLAND wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).